Diagnos (TSE:ADK) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Diagnos Inc., an AI tech firm, completed a private placement raising $2.5 million by selling units at $0.30 each, including shares and warrants. The funds will advance AI-based health screening services and support general operations. The warrants allow purchasing additional shares at $0.40 until March 2026.
For further insights into TSE:ADK stock, check out TipRanks’ Stock Analysis page.
